Healthcare company Forest Laboratories provides antibiotic drug company Nabriva Therapeutics with $25m for a new drug, and wins exclusive right to acquire the company.
Forest Laboratories has provided Nabriva Therapeutics with $25m to fund and collaborate on the company’s new antibiotic drug during the next 12 months.
During the 12-month period, Forest has the exclusive right to acquire Nabriva.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
